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Edited by Berend WieringaAbstract The mitochondrial respiratory uncoupling protein 1
(UCP1) partially uncouples substrate oxidation and oxidative
phosphorylation to promote the dissipation of cellular biochemi-
cal energy as heat in brown adipose tissue. We have recently
shown that expression of UCP1 in 3T3-L1 white adipocytes re-
duces the accumulation of triglycerides. Here, we investigated
the molecular basis underlying UCP1 expression in 3T3-L1 adi-
pocytes. Gene expression data showed that forced UCP1 expres-
sion down-regulated several energy metabolism pathways; but
ATP levels were constant. A metabolic ﬂux analysis model was
used to reﬂect the gene expression changes onto metabolic pro-
cesses and concordance was observed in the down-regulation of
energy consuming pathways. Our data suggest that adipocytes
respond to long-term mitochondrial uncoupling by minimizing
ATP utilization.
 2007 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Adipocytes1. Introduction
Obesity is a chronic condition that develops due to excess
accumulation of fats in adipose tissue and skeletal muscle,
and increases the risk of many diseases including type 2 diabe-
tes [1]. Hypertrophic expansion of white adipose tissue (WAT)
results from the progressive accumulation of intracellular lip-
ids (triglyceride, TG) [2]. Brown adipose tissue (BAT),
although sharing many features with WAT, is not present in
adult humans, and is specialized for adaptive thermogenesis
[3] through expression of high levels of fatty acid oxidation en-
zymes and mitochondrial respiratory chain components. Of
these, the mitochondrial respiratory uncoupling protein 1
(UCP1) is speciﬁcally enriched in BAT, while only minimally
expressed in WAT [4]. In BAT, UCP1 dissipates the mitochon-
drial membrane potential by partially uncoupling substrate
oxidation and oxidative phosphorylation, and promotes the
dissipation of biochemical energy as heat [5]. Recent work*Corresponding author. Fax: +1 979 845 6446.
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doi:10.1016/j.febslet.2007.11.064from our laboratory [6] has demonstrated that forced expres-
sion of UCP1 in 3T3-L1 adipocytes reduces accumulation of
TG, which is consistent with the energy dissipative function
of UCP1 reported by others [5,7]. Our data also suggested that
the reduction in TG was due to down-regulation of fat synthe-
sis, rather than an up-regulation of fatty acid oxidation.
In this study, we investigated the molecular basis of forced
UCP1 expression in 3T3-L1 adipocytes. Microarrays were
used to proﬁle changes in gene expression and identify signiﬁ-
cantly altered metabolic genes/processes. A metabolic ﬂux
model was also used to determine ﬂuxes through the energy
metabolism pathways. Our data suggest that adipocytes re-
spond to constitutive UCP1 expression by increasing protein
stability and decreasing expression of genes encoding for en-
ergy-intensive processes, thereby minimizing energy utilization
and maintaining constant ATP levels.2. Materials and methods
2.1. Reagents and cell culture
3T3-L1 preadipocyte cells were obtained from ATCC (Manassas,
VA). All tissue culture reagents including Dulbeccos modiﬁed Eagles
Medium (DMEM, 4.5 g/L glucose), calf serum (CS), fetal bovine ser-
um (FBS) were purchased from Hyclone (Logan, UT). Human insulin
and penicillin/streptomycin were purchased from Sigma (St. Louis,
MO). Null-plasmid transfected 3T3-L1 preadipocytes (referred to as
control adipocytes in this paper) and UCP1 expressing preadipocytes
were cultured and diﬀerentiated into mature adipocytes as previously
described [6]. Growth medium was replenished every other day
through day 10 post-diﬀerentiation until cells were harvested for
RNA isolation and/or mitochondrial isolation.2.2. RNA extraction
Three independent cultures were used for extracting RNA from con-
trol and UCP1 expressing adipocytes. Total RNA was isolated from
approximately 1 · 106 adipocytes at day 10 post-diﬀerentiation using
the Nucleospin II RNA isolation kit from Clontech (Palo Alto, CA).
RNA quality was determined on an Agilent 2100 Bioanalyzer (Agilent,
CA), aliquoted, and stored at 80 C until further use.
2.3. Microarray analysis
RNA extracted from control and UCP1 expressing adipocytes were
labeled and hybridized to Codelink mouse whole genome bioarrays
(GE Healthcare Sciences, NJ) with 36000 mouse gene targets. Label-
ing and hybridization experiments were performed at the Genomics
core facility, Center for Environmental and Rural Health, Texas
A&M University. Brieﬂy, cDNA was synthesized from 2 lg of total
RNA, puriﬁed, transcribed in vitro to yield biotin-labeled cRNA,blished by Elsevier B.V. All rights reserved.
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provided by the manufacturer. Arrays were hybridized for 24 h,
washed, and scanned on a Genepix 4000 microarray scanner (Mole-
cular Devices, CA). Labeled cRNA from each control or UCP1 adipo-
cyte sample was hybridized to a single microarray (total of six
microarrays). The expression data are available from the NCBI Gene
Expression Omnibus (GEO, http://www.ncbi.nlm.nih.gov/geo/) and
are accessible through GEO Series accession number GSE6643. The
data were ﬁltered to include only genes that were fully annotated
and were present in all three replicate arrays. A one-way ANOVA ﬁlter
was used to test each gene independently for a statistical diﬀerence in
expression between the UCP1 and control cells with a cutoﬀ P-value of
0.05. The expression of nine genes was determined using quantitative
RT. The mRNA sequence for each gene was retrieved from the Gen-
bank database and gene speciﬁc primers designed for each transcript
(Supplementary Table S3). RT-PCR was performed with 50 ng of
RNA using the Superscript II one-step RT-PCR kit (Invitrogen, CA)
on a icycler real-time PCR machine (Bio-Rad, Hercules, CA). The
cycle number at which the ﬂuorescence in each ampliﬁcation reaction
increased beyond a threshold (in the exponential phase of ampliﬁca-
tion) was determined using the MyiQ software (Bio-Rad). Threshold
cycle numbers for each gene were normalized to that of 18S rRNA
(housekeeping gene) as described earlier [8]. All RT-PCR experiments
were done in triplicate and data reported are means ± S.D.
2.4. Metabolite assays
As inputs for the ﬂux calculation, the rates of uptake, output, or
accumulation of 26 primary metabolites were measured by performing
assays on cell lysates and spent medium samples. Cellular ATP was
measured using a luminescence assay kit (Promega, Madison, WI)
based on the ATP-dependent activity of luciferase. TG, glycerol, and
free fatty acids (FFA) were measured using commercial assay kits as
described previously [9]. Glucose, lactate, acetoacetate, and b-hydroxy-
butyrate were measured using enzymatic assays [9]. Ammonia and
amino acids were quantiﬁed by HPLC [10]. All metabolite data were
normalized by the corresponding DNA content of the corresponding
cell sample.2.5. Metabolic ﬂux analysis
A stoichiometric model of adipocyte central carbon metabolism was
constructed as described previously [9]. The model consisted of the fol-
lowing pathways: glycolysis, glycerogenesis, ketone body synthesis,
lipogenesis, lipolysis, the malate cycle, the pentose phosphate pathway
(PPP), and the TCA cycle (Supplementary Table S1). The same model
was applied to both the control and UCP1 expressing cells. As before,
pathways were included (or omitted) based on physiological consider-
ations as well as direct observations on the net rates of uptake or out-
put of major metabolites. For example, fatty acid oxidation in UCP1
expressing cells was assumed to be negligible (compared to lipogenesis
and lipolysis) based on the observation that the oxygen utilization rate
remained unchanged relative to control cells [6]. Intracellular ﬂuxes
were estimated by solving a constrained quadratic programming prob-
lem [11]:
Minimize :
X
k
ðvk  vobsk Þ 8k 2 fexternal fluxesg
Subject to : S  v ¼ 0 ð1Þ
G  v 6 0 ð2Þ
where the objective is to minimize the sum squared error between
experimentally observed and calculated exchange ﬂuxes. Eq. (1) ex-
presses the balances around intracellular metabolites using an M  N
stoichiometric matrix S and an N  1 steady-state ﬂux distribution vec-
tor v. Inequality (2) expresses constraints derived from the Gibbs free
energy change form of the Second Law applied to pathways, as op-
posed to individual reactions.
2.6. Proteomic analysis
Protein expression levels in adipocytes expressing UCP1 were deter-
mined using quantitative iTRAQ mass spectrometry (Applied Biosys-
tems, CA). Adipocyte mitochondrial proteins were isolated using the
protocol described by Pallotti and Lenaz [12], except that the initial cell
lysis was performed in the tissue culture dish. Mitochondrial proteins
from control or UCP1 expressing adipocytes were digested with tryp-sin and the peptides tagged with diﬀerent isobaric mass tags. Equal
amounts of tagged peptides from each sample were mixed together
and separated on a strong cation exchange (SCX) column. Peptides
from six SCX fractions were further separated using reverse phase
chromatography on a 150 lm · 10 cm column (Vydac) using an
LC-Packings autosampler and pumps (LC Packings, Sunnyvale,
CA). A gradient of 2–40% acetonitrile was used to elute the peptides
from the column at a ﬂow rate of 1 lL/min. MALDI matrix (5 mg/
mL a-cyano-4-hydroxycinnamic acid) was mixed with the column
eluant through a ‘‘T’’ junction at 1.4 ll/min and spotted directly onto
a MALDI sample plate using an LC-Packings Probot.
All MALDI-MS experiments were performed using a 4800 Proteo-
mics Analyzer (Applied Biosystems, Foster City, CA). Data were ac-
quired with the reﬂectron detector in positive mode (700–4500 Da,
1900 Da focus mass) using 800 laser shots (40 shots per sub-spectrum)
with internal calibration. Collision induced dissociation tandem MS
spectra were acquired using air at the medium pressure setting as the
collision gas with 1 kV of collision energy. All MS and MS/MS data
were searched against the Swiss-Prot protein sequence database using
the GPS Explorer (Applied Biosystems) software.3. Results
3.1. Changes in adipocyte gene expression upon UCP1
expression
Approximately, 10% (3764 genes) of the 36000 mouse
genes represented on the Codelink whole genome bioarray
passed the annotation, replicate, and ANOVA ﬁlters and were
designated as signiﬁcantly expressed in UCP1 adipocytes rela-
tive to control adipocytes. The signiﬁcantly activated or re-
pressed genes were organized into 12 functional categories
based on the gene ontology annotations provided along with
the Codelink array. Fig. 1 shows the distribution of 1231
categorized genes over the diﬀerent ontology categories. Four
ontology categories – metabolism, signaling, transport, and
transcriptional regulation – accounted for 60% of all signiﬁ-
cantly altered genes. Not surprisingly, metabolism genes were
the single largest ontology category (239 genes or 19% of to-
tal). Genes involved in signaling, transport, and transcriptional
regulation accounted for 16%, 14%, and 10%, respectively.
Interestingly, apoptosis genes were also signiﬁcantly expressed
in UCP1 expressing adipocytes. This included both pro- (e.g.,
caspase-1, Bcl associated death promoter) and anti- (e.g., B-
cell leukemia/lymphoma 2, HSP40) apoptotic genes. Presum-
ably, the forced UCP1 expression resulted in an increase in
apoptosis that was countered by the change in the expression
of anti-apoptotic genes. However, the sequence of these events
remains to be conﬁrmed with further time-course experiments.
Given the known role of UCP1 in energy metabolism, we limit
our discussion to describing alterations in the expression of
metabolic genes.
3.2. Alterations in the expression of genes involved in metabolic
processes upon UCP1 expression
A majority of the metabolic genes demonstrating a signiﬁ-
cant change in expression upon UCP1 expression were
down-regulated (200 out of 239). This included genes involved
in glycolysis (e.g., hexokinase, HK; phosphofructokinase,
PFK; glyceraldehyde-3-phosphate dehydrogenase, GAPDH;
aldolase), pentose phosphate pathway (hexose-6-phosphate
dehydrogenase), glycogen metabolism (e.g., glycogen phos-
phorylase, glycogen synthase), citric acid cycle (e.g., citrate
synthase, succinate dehydrogenase, fumarase, pyruvate dehy-
drogenase), oxidative phosphorylation (e.g., ATP synthases,
Adhesion & ECM (6%)
Apoptosis (2%)
Growth (5%)
Inflammation (6%)
Metabolism (35%)
Signaling (12%)
Transcriptional regulation (11%)
Transport (10%)
DNA synthesis & repair (2%)
Protein synthesis & processing (12%)
Fig. 1. Functional classiﬁcation of statistically signiﬁcant genes. Fully annotated genes which were determined to exhibit a statistically signiﬁcant
change in expression between control and UCP1 adipocytes were classiﬁed based on their biological function using deﬁnitions in the Codelink array
(GE Healthcare).
Table 1
Metabolic processes altered upon UCP1 expression in 3T3-L1 adipo-
cytes
Pathway or process Number of genes
Glycolysis and related enzymes 15
Glycerolneogenesis and pentose
phosphate pathway
3
Glycogen metabolism 4
Citric acid cycle 6
Oxidative phosphorylation 17
Amino acid, aromatic compound
and purine metabolism
11
Lipid catabolism 17
Lipid biosynthesis 5
Uncoupling proteins 2
Cytochrome P450 enzymes 9
Apolipoproteins 6
Miscellaneous 24
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lism (e.g., carnitine acyltransferase, acyl coA dehydrogenase),
and lipid synthesis (e.g., fatty acid synthase, butyryl coA syn-
thetase). A summary of changes in expression is shown in Ta-
ble 1 and a complete list is included in Supplementary Table
S2. For several of these processes (e.g., citric acid cycle), all sig-
niﬁcantly expressed genes were down-regulated. Pyruvate ki-
nase (PK) was the only gene encoding for a glycolysis
enzyme that was up-regulated. Interestingly, PK activity re-
sults in the net formation of ATP, while HK, PFK, and GAP-
DH all result in the phosphorylation of the substrate with
either ATP (HK and PFK) or inorganic phosphate (GAPDH)
as donors. UCP1 expression in 3T3-L1 adipocytes up-regu-
lated the expression of genes involved in glycerogenesis (e.g.,
phosphoenol pyruvate carboxykinase, glucose-6-phosphatase),
detoxiﬁcation (e.g., cytochrome P450 2E1, 4B1), and apolipo-
proteins (e.g., apolipoprotein D, apolipoprotein E receptor).
Quantitative RT-PCR was used to corroborate the changes
in the expression of several genes, including UCP1, fatty acid
synthase, pyruvate kinase, and cytochrome P450 2E1 (Supple-
mentary Table S3).
3.3. Estimation of metabolic ﬂux in UCP1 expressing adipocytes
Regulation of biochemical activity occurs at multiple levels,
including by post-translational modiﬁcation of enzymes and
substrate availability. Therefore, we determined the ﬂux
through the diﬀerent energy metabolism pathways at day 10
post-diﬀerentiation using a metabolic ﬂux model and com-
pared the changes in reaction ﬂuxes with the corresponding
gene expression data (Fig. 2). Signiﬁcant changes were esti-
mated for 12 of the 66 reactions included in the model. These
were the reactions of glycolysis (Nos. 4 and 7, see Supplemen-
tary Table S1), lipid metabolism (Nos. 25–27), amino acid
metabolism (Nos. 31, 35, and 48) and plasma exchange
(Nos. 53, 55, and 66). These changes reﬂected an increase in
the conversion of glycerone-phosphate into glyceraldehyde 3-
phosphate (by 81%) and an increase in lactate output (by
168%). As a result, the net inﬂux of pyruvate into the TCA cy-
cle remained unchanged, but the supply of glycerone-phos-
phate for fatty acid esteriﬁcation, and thus net TG synthesis,
was signiﬁcantly reduced (by 36%).Changes at the level of metabolite ﬂuxes should lag tran-
scriptional events, because of the many intervening layers of
biochemical regulation. Therefore, we also obtained a second
snapshot of the metabolic state at a later time point. On day
14, signiﬁcant changes were estimated for 11 of the 60 reac-
tions. These were the reactions of the PPP (Nos. 8 and 9), gly-
colysis (Nos. 2 and 7), lipid metabolism (Nos. 24–27), and
alanine production (Nos. 35 and 53). The ﬂux changes clus-
tered essentially around two branch points: pyruvate and free
fatty acid. Forced expression of UCP1 decreased the PPP ﬂux
by 67%, while increasing lactate output by 410%. The net in-
ﬂux of pyruvate into the TCA cycle was unchanged, as were
the TCA cycle ﬂuxes. The PPP is a major producer of NADPH
for de novo fatty acid synthesis. As expected, its down-regula-
tion correlated with a 47% attenuation of acetyl-CoA export
from the TCA cycle (via the citrate pool). A similar reduction
(45%) was also estimated for FFA esteriﬁcation into TG and
the liberation of free glycerol by way of lipolysis.
Together, the metabolic ﬂux data show that the PPP, fatty
acid biosynthesis, and glyceroneogenesis were all signiﬁcantly
decreased whereas fermentation of pyruvate was increased by
UCP1 expression. Changes in PPP, fatty acid biosynthesis,
and glyceroneogenesis were observed at the transcriptional le-
vel as well.
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Fig. 2. Comparison of changes in gene expression and metabolite levels determined from metabolic ﬂux analysis. Pathways signiﬁcantly altered at
both the metabolite level and gene expression are indicated by a dashed line. The fold-change in ﬂux between UCP1 and control adipocytes as well as
the number of genes diﬀerentially expressed for each process is also indicated. In addition, pathways that were signiﬁcantly altered either at the
metabolite level or at the gene expression level only are also shown. Flux values at days 10 and 14 are given (day 10 value/day 14 value) and NS
denotes statistically insigniﬁcant change in metabolite ﬂux.
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Microscopy images indicated that UCP1 expressing adipo-
cytes exhibited a characteristic morphology (round shape andA B
C D
100 μm
Fig. 3. Phase contrast (A and B) and Oil-Red O stained (C and D) images of
Scale bar length is 100 lm.visible lipid droplets) (Fig. 3A and B) consistent with the
known phenotype of diﬀerentiated 3T3-L1 adipocytes [13].
However, Oil-Red O staining showed that at day 10 post-induc-UCP1 expressing and control adipocytes at day 10 post-diﬀerentiation.
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ible lipid droplets (Fig. 3C and D). Our data show that the
intracellular ATP levels at day 10 after diﬀerentiation are iden-
tical between the UCP1 expressing and control adipocytes (6.25
vs. 6.27 mMol-ATP/g-DNA). Together with the gene expres-
sion and metabolite ﬂux data, these results indicate that while
the overall energy metabolism ﬂux is decreased, the ATP levels
are maintained constant upon UCP1 expression.4. Discussion
In this study, we used DNA microarrays and metabolic ﬂux
analysis to investigate at the molecular level the eﬀect of con-
stitutive UCP1 expression in 3T3-L1 adipocytes. UCP1 is a
brown adipocyte protein that participates in non-shivering
thermogenesis by lowering the mitochondrial membrane po-
tential and promoting energy dissipation. Since UCP1 is only
minimally expressed in white adipocytes, our interest was to
determine the eﬀect of exogenous UCP1 expression in white
adipocyte gene expression and energy metabolism. We have
previously shown that constitutive expression of UCP1 in
3T3-L1 adipocytes decreased lipid levels by decreasing fat syn-
thesis rather than promoting fat oxidation. The gene expres-
sion data presented here indicate that UCP1 expression
down-regulates the expression of several genes involved in en-
ergy metabolism (Table 1), including PPP, TCA cycle, lipid
biosynthesis and catabolism. The observed changes in expres-
sion likely reﬂect cellular adaptation to long-term stress as the
expression of UCP1 was constitutive (so as to mirror the con-
ditions described in our prior work [6]), which can lead to de-
crease in the expression of genes involved in energy yielding
and consuming processes.
Even with continuous expression of UCP1, ATP levels were
similar between control and UCP1 adipocytes. This is surpris-
ing, as expression of UCP1 is expected to reduce the eﬃciency
of oxidative phosphorylation, and decrease ATP levels in adi-
pocytes. Although it is possible that compensatory mecha-
nisms are present to utilize other energy sources (e.g., fatty
acids) for maintaining ATP levels, our gene expression and
metabolic ﬂux data instead suggest down-regulation of lipidTable 2
Statistically signiﬁcant changes in the expression of ubiquitin protease-relate
Gene
Ubiquitin-activating enzyme E1, Chr Y 1 (Ube1y1)
Proteasome (prosome, macropain) subunit, alpha type 1 (Psma1)
Ariadne ubiquitin-conjugating enzyme E2 binding protein
homolog 1 (Drosophila) (Arih1)
Ubiquitin speciﬁc protease 27, X chromosome (Usp27x)
F-box and leucine-rich repeat protein 12 (Fbxl12)
Proteasome (prosome, macropain) subunit, alpha type 7 (Psma7)
Ubiquitin speciﬁc protease 10 (Usp10)
Proteasome (prosome, macropain) subunit, beta type 1 (Psmb1)
Ubiquitin speciﬁc protease 39 (Usp39)
Ubiquitin-conjugating enzyme E2, J1 (Ube2j1)
Ubiquitin protein ligase E3A (Ube3a), transcript variant 2
Ubiquitin speciﬁc protease 3 (Usp3)
Ubiquitin speciﬁc protease 3 (Usp3)
General transcription factor III A (Gtf3a)
Ubiquitin protein ligase Nedd-4 mRNA
Adult male aorta and vein cDNA, RIKEN clone:
A530064N14 product:unknown EST, full insert sequencecatabolism pathways. The lack of direct correlation between
UCP1 expression and lipid catabolism is also consistent with
the observations of Enerba¨ck et al. [14] who showed that
UCP1 knockout mice are not obese (i.e., as would be expected
if UCP1 expression results in increased lipid catabolism).
Based on the gene expression and metabolic ﬂux changes, we
hypothesize that the UCP1 expressing adipocytes maintained
their ATP levels by minimizing ATP utilization (i.e., through
the down-regulation of energy-dependent molecular pro-
cesses). This is supported by the gene expression data (accessi-
ble through the GEO accession number GSE6643) showing
that the expression of several signaling kinases that require
ATP for function are down-regulated with UCP1 expression.
The gene expression trends are also consistent with results at
the level of protein expression. Analysis of 100 mitochondrial
proteins, including those involved in electron transport chain
(n = 23), TCA cycle (n = 17) and glycolysis (n = 3), in control
and UCP1 expressing adipocytes by quantitative iTRAQ mass
spectrometry [15] shows that 90 mitochondrial proteins are
down-regulated in UCP1 adipocytes relative to control, with
an average fold-change of 0.77 ± 0.18.
The notion that adipocytes expressing UCP1 minimize en-
ergy expenditure can also be inferred from the changes in the
expression of genes encoding for glycolytic enzymes. Our data
(Table 1) show that pyruvate kinase, the only glycolytic en-
zyme that results in direct production of ATP (without the
additional steps of electron transfer and oxidative phosphory-
lation), is also the only glycolysis gene up-regulated in UCP1
expressing adipocytes (1.18-fold; P = 0.0015). However, eight
other glycolysis genes that either utilize ATP or do not pro-
duce ATP (e.g., hexokinase, aldolase) are down-regulated
upon UCP1 expression. Our data suggest a scenario where
UCP1 expression in 3T3-L1 adipocytes up-regulates reactions
that generate ATP directly, as opposed to those that generate
ATP by way of reducing potential for subsequent oxidative
phosphorylation.
Our data show that the expression of 15 genes related to the
ubiquitin proteasome system and other proteases (Table 2)
were signiﬁcantly down-regulated in UCP1 adipocytes. Since
these proteases are involved in protein degradation and turn-
over, their down-regulation is expected to increase the overalld genes upon UCP1 expression in 3T3-L1 adipocytes
P-value Expression
ratio
0.046 1.47
0.006 1.74
0.012 1.43
0.038 1.21
0.030 1.23
0.029 1.24
0.039 1.32
0.023 1.36
0.017 1.36
0.011 1.70
0.014 1.41
0.026 1.32
0.022 1.34
0.046 1.29
0.004 1.35
0.035 1.47
Mitochondria
UCP1
Protein
stability
Energy
metabolism
=
UBQ
+ -
Energy
dependent
processes
-
ATP
=
X X
-
Fig. 4. Proposed model for eﬀects of constitutive long-term expression
of UCP1 in 3T3-L1 adipocytes.
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which would normally be degraded at a certain rate will be
present and active for much longer in UCP1 expressing adipo-
cytes. The long half-life of metabolic enzymes, in turn, can
obviate the need for further de novo synthesis of these enzymes,
thereby minimizing the energy requirement of the cell. This
ATP utilization hypothesis is consistent with the earlier work
of Buttgereit and Brand [16] that showed the existence of a
distinct hierarchy of ATP consumption in concovalin A-
treated thymocytes, with protein synthesis and DNA/RNA
synthesis being most sensitive to ATP supply. Therefore, we
propose that UCP1 expressing adipocytes down-regulate gene
expression to maintain ATP levels constant. Interestingly, the
study by Buttgereit and Brand found that the mitochondrial
proton leak is among the least sensitive to ATP supply, which
is also consistent with our observations (Supplementary Table
S2).
The correspondence between changes in gene expression and
enzyme activity was mixed. While some processes such as PPP
and fat biosynthesis were decreased at both levels (as evi-
denced by decrease in the expression of multiple genes involved
in these processes), others such as lactate production and oxi-
dative phosphorylation were altered only at the metabolic ﬂux
or gene expression level, respectively. Our data suggests that
multiple levels of regulation are utilized by 3T3-L1 adipocytes
in the response to continuous mitochondrial uncoupling. Cur-
rently, it is not clear why certain processes are down-regulated
at both the gene expression and metabolite levels while some
others appear to be controlled only at one of the levels. One
possibility is that only processes which directly yield ATP
(e.g., glycolysis) are regulated at both the gene expression
and metabolite ﬂux levels (i.e., more tightly regulated).
Based on our data, we propose a model for changes in en-
ergy metabolism occurring upon forced expression of UCP1
in adipocytes (Fig. 4). In this model, the primary long-term re-
sponse of adipocytes to constitutive mitochondrial uncoupling
is to minimize ATP utilization through a combination of: (i)
down-regulation of ATP-dependent molecular processes such
as the expression of signaling kinases and (ii) increasing the
half-life of metabolic enzymes through down-regulation of
ubiquitin proteases, thereby minimizing the energy demands
arising from transcription and translation. Based on these re-
sults, we hypothesize that ATP conservation is a manifestation
of adaptation to long-term constitutive uncoupling. Current
work in our laboratory focuses on comparing alterations in en-
ergy metabolism at the gene expression and metabolite levels
by regulating UCP1 expression in adipocytes using doxycy-
cline and the Tet-Oﬀ expression system [6].
Increasing energy expenditure in white adipocytes has been
proposed as an alternative or complement to current obesitytherapies, which are generally aimed at reducing bodily nutri-
ent intake. A number of in vitro studies have explored the
induction of UCP1 through upstream activators as a means
to enhance oxidative metabolism in white adipocytes [17–19].
Our ﬁndings also suggest that long-term UCP1 expression
could attenuate adipocyte lipid accumulation, albeit through
a mechanism that does not involve increased substrate oxida-
tion. Prospectively, UCP1 and perhaps other mitochondrial
membrane proton carriers could be developed as targets
for pharmacological agents to treat obesity at the cellular
level.
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